Skip to main content
Signal8

WALDW (WALDW)

Waldencast plc logo

Waldencast plc

NASDAQ:WALDWConsumer Defensive
Mkt Cap-
Float12.57M
O/S-
Inst Own-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorConsumer Defensive
IndustryHousehold & Personal Products
ExchangeNASDAQ
CountryGBGB
IPO Date-
Shares Outstanding-
Float12.57M
Company Overview

Waldencast plc specializes in sophisticated skincare solutions, offering advanced treatments designed to diminish the appearance of premature aging, alleviate skin damage, correct hyperpigmentation, manage acne, and mitigate the effects of sun exposure. These products are predominantly distributed through a professional network that includes dermatologists, plastic surgeons, medical spas, and other certified skincare experts.

The company's portfolio features Obagi Medical, a line of transformative skincare products formulated to visibly reduce signs of aging, target issues such as dark spots, uneven pigmentation, fine lines, and wrinkles, while simultaneously safeguarding and enhancing overall skin tone and texture.

Additionally, Obagi Clinical provides skincare offerings specifically developed to proactively prevent the onset of early aging symptoms. Established in 1988, the company is based in White Plains, New York.

Leadership

Elisabeth Milan

General Counsel

Felipe Dutra

Chairman of the Board, Principal Executive & Financial Officer & Interim CEO

Employees

--

Country

GB

Sector

Consumer Defensive

Website

waldencast.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trading
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(18)
--
Insiderⓘ
(7)
--
5%+ Owners
(4)
--
Unattributed (incl. retail)ⓘ
Top Shareholders
NameShares%
Zeno Investment Master Fund logo
Zeno Investment Master Fund
· may incl. warrants· reaffirmed 13D/A Jul 2025
20.5M18.8%
Zeno Equity Partners LLP logo
Zeno Equity Partners LLP
· also on 13F· may incl. warrants· filed Jul 2025
17.1M14.5%
Santa Venerina Inv. & Arbitrage Ltd. logo
Santa Venerina Inv. & Arbitrage Ltd.
· may incl. warrants· filed Jun 2026
15.0M12.7%
FVF PARTICIPACOES LTDA. logo
FVF PARTICIPACOES LTDA.
· may incl. warrants· filed Sep 2025
7.0M6.1%
Fitpart Fund Administration Services Ltd. logo
Fitpart Fund Administration Services Ltd.
· may incl. warrants· filed Aug 2025
5.0M4.4%
Zeno Equity Partners LLP logo
Zeno Equity Partners LLP
WALDW
4.9M--
TRUXT Investimentos Ltda logo
TRUXT Investimentos Ltda
· filed Jan 2024
4.1M4.8%
Dynamo Internacional Gestão de Recursos Ltda. logo
Dynamo Internacional Gestão de Recursos Ltda.
· filed Dec 2023
1.1M1.1%
LMR Partners LLP logo
LMR Partners LLP
WALDW
1.1M--
Brousset Michel profile photo
Brousset Michel
Chief Executive Officer, Director
952.9K--
Sources: 13F, Form 4, 13D/13G
Insiders & Institutional Holders
52-Week Range
Volume
Average Daily Volume939.40K

30d Avg

939.40K

60d Avg

543.01K

90d Avg

309.64K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...